Evidence map›Paper›PMID 20566332›Full record

ArticleReproductive toxicology (Elmsford, N.Y.)2010

Alterations in the developing testis transcriptome following embryonic vinclozolin exposure.

Tracy M Clement, Marina I Savenkova, Matthew Settles, Matthew D Anway, Michael K Skinner

Open access · greenAbstract read
In one paragraph

Article in Reproductive toxicology (Elmsford, N.Y.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Tracy M ClementCenter for Reproductive Biology, School of Molecular Biosciences, Washington State University, Pullman, WA 99164-4236, USA.
Marina I Savenkova
Matthew Settles
Matthew D Anway
Michael K Skinner
Washington State University · US

Funding

EPIGENETIC TRANSGENERATIONAL ENDOCRINE DISRUPTOR ACTIONSR01ES012974 · NIEHS · WASHINGTON STATE UNIVERSITY · PI SKINNER, MICHAEL K · 2005 to 2018
$4.6M
NIEHS NIH HHS R01 ES012974
6 · The paper itself

Abstract

The current study investigates the direct effects of in utero vinclozolin exposure on the developing F1 generation rat testis transcriptome. Previous studies have demonstrated that exposure to vinclozolin during embryonic gonadal sex determination induces epigenetic modifications of the germ line and transgenerational adult onset disease states. Microarray analyses were performed to compare control and vinclozolin treated testis transcriptomes at embryonic days 13, 14 and 16. A total of 576 differentially expressed genes were identified and the major cellular functions and pathways associated with these altered transcripts were examined. The sets of regulated genes at the different development periods were found to be transiently altered and distinct. Categorization by major known functions of altered genes was performed. Specific cellular process and pathway analyses suggest the involvement of Wnt and calcium signaling, vascular development and epigenetic mechanisms as potential mediators of the direct F1 generation actions of vinclozolin.

Indexed as

Gene Expression ProfilingAnimalsEmbryonic DevelopmentEndocrine DisruptorsFemaleGene Expression Regulation, DevelopmentalGestational AgeMaleOligonucleotide Array Sequence AnalysisOxazolesPregnancyRatsRats, Sprague-DawleyTestisEndocrine DisruptorsOxazolesvinclozolin

Identifiers

PMID20566332
PMCPMC2944409
OpenAlexW2029470295

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.